Research and Markets (http://www.researchandmarkets.com/research/8da6f9/ceo_360_degree_per) has announced the addition of Frost & Sullivan's new report "CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology" to their offering.
This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000 end-user interviews approximately 50,000 hours of analyst research, in the last 2 years. Global healthcare analysts from Frost & Sullivan have contributed their market knowledge to cover the most important issues that are relevant in the healthcare industry today. The report also includes research findings from econometric, advanced technology and several other business divisions of Frost & Sullivan.
Key Topics Covered:
Global Perspective
- Shifting Global Clinical Trial Dynamics
- Shift In Growth From Mature Markets To Emerging Markets
Integrated Industry Perspective
- Adaptation To Changing Business Models
- Consolidation of Pfizer and Wyeth
- Convergence of Healthcare Allows for Personalization
- Move from Transactional to Strategic Outsourcing Partnerships Encourages Standardization of LIMS
Technology Perspective
- Oral Oncology Drugs Increasing in Importance
- Advances in Genomics Promotes Healthcare Paradigm Shift
- Effective Screening Methods to Select the Most Promising Drug Candidates
- Growth of Vaccines Market Boosting Technology Innovation
- Gene Therapy Driving Market
Economic Perspective